What I did
Campaign design | Artwork
Living with asthma often means a life of constant vigilance—avoiding triggers, checking air quality, and worrying about how stress or weather might affect your breathing. It’s exhausting and can feel never-ending. This clinical trial focuses on a JAK inhibitor inhaler that directly targets JAK1 in the lungs with a low-dose treatment. It’s an opportunity for participants to take a proactive step toward gaining more control over their asthma and reducing the relentless impact of daily triggers. The concept of “Untriggered” became our guiding light for this pitch, showing how the trial could help participants feel calmer and more in control of their condition.
The “Untriggered” concept formed the backbone of the pitch, highlighting how this clinical trial could offer real relief to participants by focusing on ease and control. The messaging needed to resonate emotionally while delivering the clinical benefits clearly. I framed the visuals and copy around the feeling of release from the constant vigilance asthma demands, using metaphors like finding calm amidst chaos.
The final pitch presented the trial as a transformative opportunity for individuals with asthma to feel “Untriggered.” Through a combination of empathetic messaging and engaging visuals, the pitch showed how the JAK inhibitor inhaler could help patients feel more at ease in their day-to-day lives.
